A Double Blind, Dose Range, Placebo Controlled Study of the Effects of Rostafuroxin vs Placebo in Patients With Stable, Uncomplicated, Essential Hypertension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The purpose of this study is to verify the efficacy of Rostafuroxin in the treatment of essential hypertension and to determine the best effective dose to be administered in the general hypertensive population and in a subset of this population in which genetic patterns could be involved in the etiology of essential hypertension.
Epistemonikos ID: 82d0484e55888b45c5dc5452398a69c99b0025a5
First added on: May 04, 2024